Coronary heart disease in postmenopausal women with type II diabetes mellitus and the impact of estrogen replacement therapy

A narrative review

Marouane Boukhris, Salvatore Davide Tomasello, Francesco Marzà, Sonia Bregante, Francesca Romana Pluchinotta, Alfredo Ruggero Galassi

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Coronary heart disease is the main cause of death in postmenopausal women (PMW); moreover its mortality exceeds those for breast cancer in women at all ages. Type II diabetes mellitus is a major cardiovascular risk factor and there is some evidence that the risk conferred by diabetes is greater in women than in men. It was established that the deficiency of endogenous estrogens promotes the atherosclerosis process. However, the impact of estrogen replacement therapy (ERT) on cardiovascular prevention remains controversial. Some authors strongly recommend it, whereas others revealed a concerning trend toward harm. This review tries to underlines the different components of cardiovascular risk in diabetic PMW and to define the place of ERT.

Original languageEnglish
Article number413920
JournalInternational Journal of Endocrinology
Volume2014
DOIs
Publication statusPublished - 2014

Fingerprint

Estrogen Replacement Therapy
Type 2 Diabetes Mellitus
Coronary Disease
Cause of Death
Atherosclerosis
Estrogens
Breast Neoplasms
Mortality

ASJC Scopus subject areas

  • Endocrine and Autonomic Systems
  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Coronary heart disease in postmenopausal women with type II diabetes mellitus and the impact of estrogen replacement therapy : A narrative review. / Boukhris, Marouane; Tomasello, Salvatore Davide; Marzà, Francesco; Bregante, Sonia; Pluchinotta, Francesca Romana; Galassi, Alfredo Ruggero.

In: International Journal of Endocrinology, Vol. 2014, 413920, 2014.

Research output: Contribution to journalArticle

@article{9a505c042eb64bac90cab4f9e44bcd16,
title = "Coronary heart disease in postmenopausal women with type II diabetes mellitus and the impact of estrogen replacement therapy: A narrative review",
abstract = "Coronary heart disease is the main cause of death in postmenopausal women (PMW); moreover its mortality exceeds those for breast cancer in women at all ages. Type II diabetes mellitus is a major cardiovascular risk factor and there is some evidence that the risk conferred by diabetes is greater in women than in men. It was established that the deficiency of endogenous estrogens promotes the atherosclerosis process. However, the impact of estrogen replacement therapy (ERT) on cardiovascular prevention remains controversial. Some authors strongly recommend it, whereas others revealed a concerning trend toward harm. This review tries to underlines the different components of cardiovascular risk in diabetic PMW and to define the place of ERT.",
author = "Marouane Boukhris and Tomasello, {Salvatore Davide} and Francesco Marz{\`a} and Sonia Bregante and Pluchinotta, {Francesca Romana} and Galassi, {Alfredo Ruggero}",
year = "2014",
doi = "10.1155/2014/413920",
language = "English",
volume = "2014",
journal = "International Journal of Endocrinology",
issn = "1687-8337",
publisher = "Hindawi Publishing Corporation",

}

TY - JOUR

T1 - Coronary heart disease in postmenopausal women with type II diabetes mellitus and the impact of estrogen replacement therapy

T2 - A narrative review

AU - Boukhris, Marouane

AU - Tomasello, Salvatore Davide

AU - Marzà, Francesco

AU - Bregante, Sonia

AU - Pluchinotta, Francesca Romana

AU - Galassi, Alfredo Ruggero

PY - 2014

Y1 - 2014

N2 - Coronary heart disease is the main cause of death in postmenopausal women (PMW); moreover its mortality exceeds those for breast cancer in women at all ages. Type II diabetes mellitus is a major cardiovascular risk factor and there is some evidence that the risk conferred by diabetes is greater in women than in men. It was established that the deficiency of endogenous estrogens promotes the atherosclerosis process. However, the impact of estrogen replacement therapy (ERT) on cardiovascular prevention remains controversial. Some authors strongly recommend it, whereas others revealed a concerning trend toward harm. This review tries to underlines the different components of cardiovascular risk in diabetic PMW and to define the place of ERT.

AB - Coronary heart disease is the main cause of death in postmenopausal women (PMW); moreover its mortality exceeds those for breast cancer in women at all ages. Type II diabetes mellitus is a major cardiovascular risk factor and there is some evidence that the risk conferred by diabetes is greater in women than in men. It was established that the deficiency of endogenous estrogens promotes the atherosclerosis process. However, the impact of estrogen replacement therapy (ERT) on cardiovascular prevention remains controversial. Some authors strongly recommend it, whereas others revealed a concerning trend toward harm. This review tries to underlines the different components of cardiovascular risk in diabetic PMW and to define the place of ERT.

UR - http://www.scopus.com/inward/record.url?scp=84928503856&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84928503856&partnerID=8YFLogxK

U2 - 10.1155/2014/413920

DO - 10.1155/2014/413920

M3 - Article

VL - 2014

JO - International Journal of Endocrinology

JF - International Journal of Endocrinology

SN - 1687-8337

M1 - 413920

ER -